Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2025 financial results
Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today.
Reported sales increased 2.4% year-over-year to $21.9 billion. Operational sales growth was 4.2%.
Net earnings rose to $11 billion, or $4.54 per share, from $3.25 billion, or $1.34 per share, last year. Adjusted EPS grew 2.2% to $2.77.
Revenue and earnings beat estimates.
The company raised its sales outlook for the full year of 2025 and now expects reported sales of $91.0-91.8 billion. Adjusted EPS guidance remains unchanged at $10.50-10.70.
JNJ also declared a 4.8% increase in its quarterly dividend, from $1.24 per share to $1.30 per share. The stock was down in premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key highlights from Pfizer’s (PFE) Q1 2025 earnings results
Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP net income decreased 5% to $2.96 billion, or $0.52 per
PYPL Earnings: PayPal reports higher Q1 2025 revenue and profit
PayPal Holdings Inc. (NASDAQ: PYPL) on Tuesday reported a modest increase in revenue for the first quarter of 2025 when the payment service giant's adjusted earnings rose by double digits.
General Motors (GM) Q1 2025 revenue and adj. earnings beat estimates
Auto giant General Motors (NYSE: GM) on Tuesday announced financial results for the first quarter of 2025, reporting an increase in revenue and adjusted profit. The results also topped expectations.
